A mong the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Since May it has offered its own version of Wegovy,

A new study suggests weight loss drugs like Ozempic and Mounjaro could provide a promising new treatment for substance use disorders.

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, thigh or stomach. They work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).

FDA approval: Ozempic is FDA-approved for Type 2 diabetes, while Wegovy is FDA-approved for weight loss. Cost: Ozempic is typically more affordable than Wegovy. At the time of publishing, the list price for Ozempic was $968.52 per month, whereas the list price for Wegovy was $1,349.02 per month. List prices are the price set by the manufacturer.

Many people use semaglutides like Ozempic for weight loss, but can you use it to lose a small amount—say, 10 or 20 pounds? Doctors explain the concerns.

A recent study revealed that weight loss medications like Ozempic and Mounjaro might help individuals battling addiction. The findings, published in the scientific journal Addiction, said that people with alcohol addiction who were prescribed these medications had a 50 per cent lower rate of binge drinking compared to those who were not.